Latest generic drug deal puts hospital-owned Civica Rx ahead of schedule

in Local Roundup

Civica Rx, the nonprofit generics company launched last year by hospitals looking to prevent drug shortages, is ahead of schedule with planned production of new drugs.

The company inked a deal with London-based Hikma Pharmaceuticals to get 14 essential sterile injectable medications into hospitals by the end of this year, it announced Tuesday. That comes after the company announced in May that it signed a five-year deal with Copenhagen-based Xellia Pharmaceuticals to make the broad-spectrum antibiotics vancomycin and daptomycin by the third quarter of this year.
Continue Reading on Fierce Health Care

Latest from Local Roundup

Go to Top